emerg
sever
acut
respiratori
syndrom
coronaviru
sarscov
guangdong
provinc
china
subsequ
spread
asia
canada
clearli
exemplifi
vulner
societi
economi
novel
highli
pathogen
respiratori
agent
stadler
et
al
peiri
et
al
outbreak
halt
sole
quarantin
expos
individu
use
convent
prevent
measur
surgic
mask
parallel
intern
collabor
scientif
effort
develop
mean
therapeut
prevent
intervent
peiri
et
al
stadler
rappuoli
basi
develop
success
antivir
strategi
thorough
understand
molecular
biolog
underli
viral
amplif
pathogenesi
mani
signific
discoveri
made
sar
field
sinc
identif
viru
earli
drosten
et
al
ksiazek
et
al
peiri
et
al
sever
find
provid
import
insight
structur
function
viral
spike
protein
use
viru
key
bind
enter
host
cell
hofmann
wellknown
exampl
identif
angiotensinconvert
enzym
host
factor
engag
viral
protein
infecti
entri
cell
elucid
structur
protein
receptor
bind
domain
rbd
complex
li
et
al
find
major
implic
vaccin
inhibitor
develop
also
understand
sar
zoonosi
sinc
adapt
sarss
robust
usag
human
probabl
key
import
effici
sarscov
spread
human
li
et
al
chapter
discuss
sarscov
gain
access
target
cell
process
inhibit
addit
review
molecular
interact
underli
sarscov
entri
impact
viral
pathogenesi
interspeci
transmiss
sarssprotein
type
transmembran
protein
compris
amino
acid
contain
consensu
signal
nlink
glycosyl
hofmann
protein
synthes
secretori
pathway
infect
cell
contain
ntermin
signal
sequenc
mediat
import
nascent
protein
endoplasmat
reticulum
protein
fold
modifi
mannoserich
carbohydr
upon
transport
protein
golgi
apparatu
highmannos
carbohydr
process
complex
glycan
nal
et
al
evid
oglycosyl
sarss
report
novel
dibas
er
retriev
motif
cytoplasm
tail
sarss
promot
accumul
protein
intermedi
compart
golgi
region
mcbride
et
al
site
progeni
particl
assembl
stertz
et
al
siu
et
al
format
bud
new
particl
driven
membran
protein
envelop
protein
e
nucleocapsid
protein
n
huang
et
al
hsieh
et
al
siu
et
al
interact
protein
might
facilit
protein
incorpor
particl
trimer
protein
protrud
viral
envelop
provid
virion
crown
lat
corona
like
appear
name
coronavirus
deriv
domain
organ
sarss
resembl
sever
wellcharacter
viral
membran
protein
influenza
viru
hemagglutinin
ha
human
immunodefici
viru
hiv
envelop
protein
env
hofmann
protein
employ
compar
strategi
facilit
fusion
viral
host
cell
membran
term
class
fusion
protein
kielian
rey
distinguish
class
ii
fusion
protein
kielian
found
exampl
flavi
alphavirus
distinct
spatial
organ
particular
configur
function
element
requir
fusion
target
cell
class
fusion
protein
insert
perpendicular
viral
membran
contain
ntermin
surfac
unit
su
ctermin
transmembran
unit
tm
globular
su
interact
cellular
receptor
tm
promot
fusion
viral
host
cell
membran
kielian
rey
latter
process
depend
presenc
fusion
peptid
two
helic
region
hr
conserv
element
intim
involv
membran
fusion
process
fig
discuss
protein
aforement
fusion
protein
adapt
usag
differ
cellular
receptor
therefor
su
term
sarss
exhibit
appreci
sequenc
homolog
respect
sequenc
class
fusion
protein
contrast
function
element
tm
particularli
hr
conserv
differ
class
fusion
protein
consequ
tm
term
sarss
share
homolog
correspond
sequenc
viral
fusion
protein
hofmann
import
implic
develop
antivir
strategi
discuss
interact
sarss
first
indispens
step
entri
cascad
discuss
need
note
howev
sarss
also
bind
cell
surfac
factor
interact
although
ultim
dispens
infecti
entri
might
profoundli
alter
infect
effici
thu
well
establish
calciumdepend
ctype
lectin
dendrit
cellspecif
intercellular
adhes
grab
nonintegrin
dcsign
geijtenbeek
et
al
relat
protein
dcsignr
lsign
et
al
bashirova
et
al
bind
sarss
marzi
et
al
yang
et
al
jeffer
et
al
khoo
et
al
glycandepend
fashion
shih
et
al
han
et
al
dcsignr
detect
lung
sarscovinfect
cell
uninfect
bystand
cell
chan
et
al
dcsign
express
found
induc
upon
sarscov
infect
yen
et
al
suggest
lectin
might
ampl
opportun
captur
sarscov
infect
individu
despit
potenti
import
role
dcsignr
sarscov
infect
consequ
dcsigndcsignr
collect
refer
dcsignr
engag
sarss
viral
infect
larg
unclear
one
group
suggest
dcsignr
function
bona
fide
receptor
facilit
viral
entri
otherwis
nonpermiss
hela
cell
han
et
al
dcsignr
also
identifi
function
screen
receptor
use
sarscov
cellular
entri
jeffer
et
al
suggest
dcsignr
might
support
viral
entri
least
certain
condit
probabl
low
effici
contrast
three
studi
fail
detect
appreci
receptor
function
dcsignr
suggest
protein
might
enhanc
infecti
entri
cell
line
marzi
et
al
yang
et
al
shih
et
al
final
contrast
aforement
studi
chan
cowork
provid
evid
dcsignr
play
protect
role
sarscov
infect
chan
et
al
thu
demonstr
dcsignrdepend
uptak
sarscov
cell
line
might
lead
viral
degrad
might
thu
reduc
viral
infect
target
cell
chan
et
al
agreement
find
evid
obtain
combin
certain
dcsignr
allel
variant
result
reduc
sarscov
uptak
cell
cultur
associ
increas
risk
sarscov
infect
human
chan
et
al
albeit
find
undisput
tang
et
al
zhi
et
al
case
function
studi
describ
common
carri
cell
line
adequ
model
type
ii
pneumocyt
major
target
sarscov
infect
ham
et
al
ding
et
al
lo
mossel
et
al
work
primari
lung
epithelium
requir
help
elucid
role
dcsignr
sarscov
infect
notabl
singl
studi
examin
impact
dcsignrspecif
antibodi
viral
spread
primari
human
airway
epithelium
cultur
interfac
observ
inhibit
sim
et
al
although
investig
lectin
inde
express
cell
examin
final
worth
mention
sarss
bind
lectin
dcsignr
ctype
lectin
lsectin
gramberg
et
al
larg
coexpress
dcsignr
consequ
interact
viral
amplif
determin
collect
clear
bind
dcsignr
relat
lectin
potenti
modul
viral
spread
vivo
remain
determin
howev
lectin
bind
augment
suppress
viral
replic
recent
describ
knockin
mice
human
dcsign
schaefer
et
al
murin
homologu
human
dcsign
knockout
mice
lanou
et
al
might
use
clarifi
question
thorough
understand
interfac
sarss
key
develop
antivir
strategi
target
viral
entri
domain
amino
acid
residu
sarss
contribut
effici
interact
protein
initi
map
mutagen
analys
studi
identifi
amino
acid
sarss
independ
fold
rbd
bind
higher
affin
full
length
protein
xiao
et
al
wong
et
al
babcock
et
al
rbd
also
shown
major
target
neutral
antibodi
et
al
sever
residu
within
amino
acid
suggest
critic
optim
engag
wong
et
al
li
et
al
addit
exploit
speciesspecif
differ
murin
rat
human
allow
map
certain
amino
acid
residu
particularli
import
receptor
function
li
et
al
result
support
extend
subsequ
solut
structur
rbd
complex
li
et
al
rbd
consist
core
fivestrand
antiparallel
extend
loop
contain
amino
acid
make
contact
extend
loop
also
term
receptorbind
motif
rbm
compris
amino
acid
li
et
al
thu
includ
residu
defin
mutagen
analysi
import
sarss
interact
wong
et
al
li
et
al
rbm
contact
ntermin
helix
loop
helic
moreov
portion
rbm
insert
short
helix
amino
acid
residu
support
previous
postul
contribut
appropri
interact
li
et
al
conform
chang
inher
peptidas
activ
impact
avail
protein
bind
site
li
et
al
agreement
observ
inhibitor
block
peptidas
activ
arrest
close
conform
inhibit
sarssdepend
entri
towler
et
al
li
et
al
collect
function
structur
studi
defin
amino
acid
sarss
facilit
tight
associ
protein
addit
result
highlight
natur
variat
sequenc
might
import
implic
sarscov
transmiss
pathogen
discuss
horsesho
bat
harbor
sarscovrel
virus
might
constitut
natur
reservoir
sarscov
lau
et
al
li
et
al
howev
sequenc
homolog
bat
human
virus
limit
lau
et
al
li
et
al
thu
protein
anim
virus
contain
rbmlike
sequenc
use
cellular
entri
ren
et
al
therefor
probabl
sarscov
introduc
human
popul
via
intermedi
host
palm
civet
harbor
virus
high
sequenc
homolog
human
sarscov
possibl
candid
guan
et
al
song
et
al
notabl
protein
human
virus
epidem
bind
human
much
higher
effici
palm
civet
counterpart
li
et
al
indic
effici
spread
human
requir
adapt
sarss
sequenc
inde
sequenc
comparison
reveal
civet
rbd
contain
four
amino
acid
chang
rel
human
sequenc
two
chang
locat
outsid
rbm
impact
receptor
interact
li
et
al
contrast
remain
two
chang
n
human
k
palm
civet
posit
human
palm
civet
posit
afflict
residu
make
direct
contact
significantli
decreas
bind
human
li
et
al
thu
might
requir
effici
spread
human
li
et
al
li
interestingli
virus
isol
sporad
sar
case
winter
associ
sever
diseas
humantohuman
transmiss
contain
serin
posit
li
et
al
indic
amino
acid
might
play
key
role
humantohuman
transmiss
viral
pathogen
potenti
zoonot
transmiss
sarscov
might
also
determin
speciesspecif
variat
sequenc
thu
murin
rat
rat
ineffici
murin
support
sarssdriven
entri
li
et
al
contain
leucin
human
histidin
mous
rat
exchang
posit
exchang
imped
format
robust
contact
sarss
therebi
prevent
murin
rat
effici
support
sarssdriven
cellular
entri
li
et
al
addit
rat
murin
receptor
contain
exchang
introduc
glycosyl
signal
glycan
ad
block
interact
sarss
decreas
receptor
function
explain
rat
less
capabl
support
sarssdriven
entri
murin
li
et
al
result
conjunct
aforement
variat
rbd
sequenc
highlight
effici
sarss
interact
might
critic
determin
interspeci
transmiss
sarscov
novel
human
coronaviru
discov
two
dutch
group
aftermath
sarscov
outbreak
van
der
hoek
et
al
fouchier
et
al
group
cov
show
high
sequenc
similar
longknown
human
cov
viru
like
group
virus
describ
time
discoveri
use
aminopeptidas
n
receptor
cellular
entri
hofmann
consid
specif
group
virus
take
account
spike
protein
share
sequenc
ident
van
der
hoek
et
al
pyrc
et
al
surpris
shown
use
cellular
entri
hofmann
et
al
find
rais
question
whether
virus
use
similar
strategi
engag
map
studi
reveal
ntermin
uniqu
region
suspect
function
rbd
fact
dispens
receptor
engag
hofmann
et
al
contrast
sever
motif
within
amino
acid
found
requir
bind
within
initi
studi
suggest
might
harbor
singl
continu
rbd
hofmann
et
al
howev
subsequ
analys
narrow
region
respons
bind
amino
acid
respect
sarss
rbmlike
motif
identifi
li
et
al
lin
et
al
sever
amino
acid
substitut
found
alter
usag
sarss
hofmann
et
al
indic
protein
might
interact
differ
surfac
interpret
undisput
li
et
al
solut
structur
complex
might
requir
clarifi
whether
sarss
recogn
differenti
case
clear
virus
employ
differ
mechan
activ
membran
fusion
protein
bound
thu
believ
upon
engag
sarscov
intern
endosom
vesicl
phdepend
cellular
proteas
cathepsin
l
activ
sarss
cleavag
simmon
et
al
contrast
low
ph
cathepsin
activ
seem
larg
dispens
entri
present
unclear
membran
fusion
trigger
huang
et
al
hofmann
et
al
global
distribut
pathogen
acquir
earli
childhood
usual
caus
sever
diseas
pyrc
et
al
observ
contrast
high
pathogen
sarscov
rais
question
viral
factor
determin
diseas
sever
protein
interact
might
play
central
role
thu
mileston
discoveri
imai
colleagu
indic
express
protect
develop
acut
respiratori
distress
syndrom
ard
imai
et
al
integr
compon
system
ra
key
regul
blood
pressur
demonstr
imai
colleagu
imai
et
al
lung
function
imai
et
al
penning
et
al
knockdown
mous
model
caus
accumul
angiotensin
ii
promot
develop
ard
signal
via
receptor
imai
et
al
penning
et
al
convers
inhibit
applic
solubl
protect
ard
imai
et
al
interestingli
solubl
form
subunit
sarss
shown
downregul
express
vitro
vivo
kuba
et
al
indic
sarss
engag
might
promot
sar
develop
even
absenc
product
infect
protein
exhibit
markedli
reduc
affin
compar
sarss
mathewson
et
al
seem
engag
receptor
differ
fashion
hofmann
et
al
suggest
differenti
downregul
sarscov
could
contribut
differenti
pathogen
virus
howev
larg
unclear
sarscov
decreas
express
effect
level
systemat
investig
notabl
recent
studi
indic
sarss
might
promot
shed
ectodomain
induc
cleavag
fig
process
seem
essenti
infecti
entri
haga
et
al
contrast
induc
appreci
shed
haga
et
al
thu
previous
observ
downregul
sarss
might
due
proteolyt
cleavag
dissoci
ectodomain
rather
intern
degrad
howev
unclear
shed
ectodomain
actual
exacerb
sar
develop
consid
solubl
protect
ard
mous
model
imai
et
al
class
fusion
protein
usual
requir
proteolyt
cleavag
transit
activ
state
hofmann
kielian
rey
howev
strategi
accomplish
proteolyt
activ
vari
mani
fusion
protein
cleav
subtilisinlik
proteas
secretori
pathway
infect
cell
proteolyt
process
protein
incorpor
virion
appli
protein
strain
murin
hepat
viru
mhv
group
ii
coronaviru
membran
fusion
reaction
subsequ
trigger
bind
cleav
protein
cellular
receptor
william
et
al
nash
buchmeier
de
haan
et
al
qiu
et
al
consequ
entri
phindepend
encompass
fusion
viral
membran
plasma
membran
target
cell
nash
buchmeier
de
haan
et
al
qiu
et
al
influenza
viru
ha
either
cleav
subtilisin
proteas
secretori
pathway
secret
proteas
present
lung
lumen
howev
subsequ
bind
receptor
determin
sialic
acid
trigger
membran
fusion
intern
endosom
vesicl
fusion
trigger
low
ph
eckert
kim
thu
infecti
entri
influenza
virus
phdepend
facilit
fusion
viral
membran
endosom
membran
eckert
kim
sarss
protein
employ
mixtur
entri
strategi
describ
present
evid
appreci
cleavag
sarss
produc
infect
cell
xiao
et
al
yang
et
al
simmon
et
al
yao
et
al
hofmann
et
al
except
singl
report
wu
et
al
document
presenc
furin
augment
sarss
activ
furin
inhibitor
block
sarscov
infect
bergeron
et
al
folli
et
al
howev
cleavag
sarss
detect
condit
bergeron
et
al
folli
et
al
instead
semin
studi
simmon
colleagu
show
sarss
activ
endosom
phdepend
proteas
cathepsin
l
upon
uptak
target
cell
cathepsin
l
activ
essenti
infecti
entri
simmon
et
al
cathepsin
b
also
contribut
sarss
activ
seem
minor
import
compar
cathepsin
l
simmon
et
al
importantli
appropri
sarss
cleavag
cathepsin
l
seem
requir
modest
conform
rearrang
sarss
simmon
et
al
induc
upon
bind
beniac
et
al
thu
sarssdriven
entri
phdepend
reli
fusion
viral
endosom
membran
yang
et
al
simmon
et
al
hofmann
et
al
howev
acid
condit
requir
cathepsin
activ
trigger
effect
sarss
simmon
et
al
cathepsin
l
cleavag
site
sarss
map
recombin
protein
employ
bosch
et
al
evid
import
sarscov
entri
lack
cathepsin
lmediat
cleavag
virionassoci
sarss
target
cell
remain
demonstr
also
unclear
cellular
proteas
cathepsin
b
l
allow
sarssdriven
entri
certain
target
cell
activ
function
factor
xa
recent
suggest
du
et
al
result
await
confirm
final
noteworthi
engin
cleavag
sarss
virusproduc
cell
ablat
need
cathepsin
activ
target
cell
watanab
et
al
find
highlight
need
analyz
sarss
cleav
primari
lung
cell
determin
cathepsin
activ
inde
requir
viral
spread
vivo
inform
pivot
effort
aim
develop
cathepsin
inhibitor
antivir
therapi
function
organ
resembl
tm
class
fusion
protein
sarssdriven
membran
fusion
reaction
follow
principl
previous
establish
class
fusion
protein
hofmann
membran
fusion
commenc
insert
fusion
peptid
target
cell
membran
fig
context
worth
note
sarss
contrast
exampl
hiv
env
influenza
ha
contain
intern
fusion
peptid
constitut
n
terminu
may
compris
amino
acid
sainz
et
al
upon
fusion
peptid
insert
subunit
connect
viral
target
cell
membran
subsequ
ctermin
hr
term
fold
back
onto
ntermin
hr
term
form
energet
stabl
sixhelix
bundl
structur
orient
antiparallel
fashion
bosch
et
al
tripet
et
al
liu
et
al
supekar
et
al
ingallinella
et
al
xu
et
al
hsu
et
al
therebi
viral
target
cell
membran
pull
close
proxim
allow
membran
merg
fig
peptid
deriv
bind
block
format
sixhelix
bundl
use
therapi
hiv
infect
est
telenti
similar
approach
success
blockad
sarscov
spread
cell
cultur
bosch
et
al
liu
et
al
zhu
et
al
yuan
et
al
ni
et
al
inhibitor
develop
potent
use
treat
hiv
infect
one
reason
decreas
potenc
might
inher
cellular
locat
membran
fusion
reaction
hiv
env
protein
drive
fusion
plasma
cell
membran
target
inhibitori
peptid
readili
access
contrast
sarscov
fuse
endosom
membran
inhibitor
must
taken
endosom
effici
block
fusion
reaction
potenti
could
present
signific
hurdl
develop
fusion
inhibitor
therapi
sarscov
infect
watanab
et
al
cellular
entri
sarscov
multistep
process
involv
format
sever
transient
intermedi
structur
particip
entri
cascad
potenti
target
inhibitor
feasibl
sever
approach
prevent
entri
alreadi
demonstr
first
step
sarss
engag
attract
target
prevent
therapeut
approach
thu
immun
rbd
shown
elicit
neutral
antibodi
et
al
monoclon
rbdspecif
antibodi
exhibit
potent
antivir
effect
anim
model
identifi
sui
et
al
rockx
et
al
zhu
et
al
addit
sarss
bind
inhibit
nonpeptid
molecul
target
receptor
huentelman
et
al
solubl
shown
block
sarscov
infect
hofmann
et
al
protect
ard
kuba
et
al
make
approach
particularli
promis
protein
also
target
lectin
bind
glycan
protein
therebi
block
viral
entri
van
der
meer
et
al
keyaert
et
al
albeit
issu
concern
potenti
toxic
antigen
remain
address
bind
uptak
target
cell
protein
must
activ
cathepsin
l
potent
cathepsin
l
inhibitor
avail
simmon
et
al
howev
role
cathepsin
l
viral
spread
vivo
remain
assess
knockout
mice
reinheckel
et
al
might
suitabl
tool
endeavour
final
inhibitor
fusion
reaction
describ
bosch
et
al
liu
et
al
zhu
et
al
yuan
et
al
ni
et
al
optim
avail
compound
gener
nonpeptid
compound
desir
summari
approach
describ
particularli
combin
thereof
allow
develop
compound
suitabl
effect
prevent
combat
futur
outbreak
sarscov
